Deadline: 22-Jun-2026
The Pfizer Quality Improvement Request for Proposals (RFP) supports projects that improve timely and guideline-based Respiratory Syncytial Virus (RSV) testing among adults admitted to emergency departments or hospitalized with respiratory symptoms. Funding of up to USD 50,000 is available for healthcare organizations and institutions implementing sustainable quality improvement initiatives that strengthen testing pathways and clinical practices within a maximum project duration of 12 months.
About the Pfizer Quality Improvement RFP on Optimizing RSV Diagnosis
The Pfizer Quality Improvement RFP is designed to improve the diagnosis and management of Respiratory Syncytial Virus (RSV) in adult healthcare settings. The initiative focuses on translating existing evidence into practical improvements in healthcare systems rather than creating new diagnostic technologies.
The program addresses gaps in the implementation of current RSV testing approaches and seeks to improve testing consistency, speed, and integration into routine healthcare delivery.
RSV is a respiratory virus that can cause severe complications among adults, especially older adults and individuals with underlying medical conditions. Timely diagnosis supports better treatment decisions, patient outcomes, and healthcare planning.
Key Focus Areas and Program Priorities
The initiative supports projects focused on improving RSV diagnosis and testing systems through:
• Improving RSV detection in emergency departments and inpatient care settings
• Strengthening laboratory testing pathways
• Integrating RSV testing into standard clinical workflows
• Improving specimen collection and sampling practices
• Reducing turnaround times for diagnostic results
• Increasing awareness of RSV testing guidelines among healthcare professionals
• Enhancing reporting systems and surveillance mechanisms
• Improving patient management and healthcare decision-making
• Creating sustainable quality improvement systems within healthcare institutions
Understanding the Main Goal of the Program
The program focuses on implementation science and healthcare quality improvement rather than product development.
Projects should:
• Identify barriers affecting current RSV testing practices
• Assess existing workflows and diagnostic gaps
• Develop measurable solutions
• Create sustainable system-level improvements
• Increase the consistency and speed of RSV testing in healthcare settings
The objective is to ensure that evidence-based RSV testing practices become integrated into routine healthcare systems.
Funding Information
Funding support under this opportunity includes:
• Maximum funding amount: Up to USD 50,000 per project
• Project duration: Maximum of 12 months
• Funding type: Quality Improvement Grant
The funding is intended to support implementation and operational improvements rather than research focused on creating new diagnostic tools.
Who is Eligible?
Applications are open to organizational entities with healthcare improvement objectives and the ability to administer grant funding.
Eligible applicants include:
• Healthcare institutions
• Academic institutions
• Professional healthcare organizations
• Government agencies
• Medical institutions
• Nursing institutions
• Dental institutions
• Pharmacy institutions
• Allied health organizations
Collaborative applications are encouraged.
Partnerships may involve:
• Multiple departments within an organization
• Multiple healthcare institutions
• Cross-disciplinary teams
The lead applicant must:
• Hold an active role within the project
• Be formally affiliated with the applicant organization
• Take responsibility for project implementation and management
Eligible Countries for Project Implementation
Projects can be implemented in:
• Austria
• Belgium
• Bulgaria
• Czech Republic
• Finland
• Greece
• Ireland
• Israel
• Luxembourg
• Netherlands
• Norway
• Poland
• Portugal
• Romania
• Slovakia
• Sweden
• Switzerland
How the Program Works
Applicants are expected to follow a structured quality improvement approach.
Step 1: Conduct a baseline assessment
• Evaluate current RSV testing practices
• Identify inefficiencies and implementation gaps
• Review testing pathways and clinical workflows
Step 2: Define measurable objectives
• Establish performance indicators
• Set improvement targets
• Define expected outcomes
Step 3: Design intervention strategies
• Improve workflows
• Strengthen testing integration
• Enhance reporting systems
• Improve awareness among healthcare staff
Step 4: Implement quality improvement activities
• Apply interventions in healthcare settings
• Train relevant teams
• Introduce process improvements
Step 5: Monitor and measure outcomes
• Track progress using data
• Compare outcomes against baseline performance
• Evaluate sustainability and long-term impact
Why This Opportunity Matters
Improving RSV diagnosis has implications for patient care and public health systems.
Potential impacts include:
• Earlier detection of RSV infections
• Better treatment decisions
• Improved patient outcomes
• Reduced delays in diagnosis
• More efficient healthcare operations
• Better disease surveillance systems
• Stronger evidence-based clinical practice
Improved testing systems may also reduce strain on healthcare systems during periods of increased respiratory disease activity.
Common Mistakes Applicants Should Avoid
Organizations preparing proposals should avoid the following:
• Proposing development of new diagnostic technologies instead of quality improvement initiatives
• Failing to provide baseline data on existing testing practices
• Creating broad objectives without measurable targets
• Proposing unrealistic implementation plans
• Ignoring sustainability considerations
• Submitting projects without strong healthcare system integration
• Failing to define clear roles for project partners
Tips for Strong Applications
• Use data to identify current challenges
• Create measurable and realistic goals
• Focus on sustainable healthcare improvements
• Demonstrate institutional support
• Show how improvements can continue after funding ends
• Include multidisciplinary collaboration where appropriate
Frequently Asked Questions (FAQs)
What is the main objective of the Pfizer RSV Quality Improvement RFP?
The initiative aims to improve timely and guideline-based RSV laboratory testing among adults in emergency and hospital settings through sustainable healthcare system improvements.
How much funding is available?
Approved projects may receive funding of up to USD 50,000.
What is the maximum project duration?
Projects must be completed within a maximum period of 12 months.
Can applicants propose new RSV diagnostic technologies?
No. The program focuses on improving implementation and use of existing diagnostic approaches rather than developing new technologies.
Who can apply?
Healthcare institutions, academic organizations, professional bodies, government agencies, and related healthcare entities may apply.
Are collaborative proposals allowed?
Yes. Collaborative proposals involving multiple institutions or departments are encouraged.
Which countries are eligible for implementation?
Projects may be implemented in Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Sweden, and Switzerland.
Conclusion
The Pfizer Quality Improvement RFP on optimizing RSV diagnosis offers healthcare organizations an opportunity to strengthen adult RSV testing systems through evidence-based and sustainable improvements. By supporting implementation-focused projects, the initiative aims to improve diagnostic efficiency, enhance patient care outcomes, and strengthen healthcare systems through better clinical practices and testing pathways.
For more information, visit Pfizer.
